SEARCH

SEARCH BY CITATION

References

  • Abdel-Hamid K. M. and Tymianski M. (1997) Mechanisms and effects of intracellular calcium buffering on neuronal survival in organotypic hippocampal cultures exposed to anoxia/aglycemia or to excitotoxins. J. Neurosci. 17, 35383553.
  • Anis N. A., Berry S. C., Burton N. R. and Lodge D. (1983) The dissociative anaesthetics, ketamine and phencyclidine, selectively reduce excitation of central mammalian neurons by N-methyl-aspartate. Br. J. Pharmacol. 79, 565575.
  • Araujo I. M., Verdasca M. J., Leal E. C., Bahr B. A., Ambrosio A. F., Carvalho A. P. and Carvalho C. M. (2004) Early calpain-mediated proteolysis following AMPA receptor activation compromises neuronal survival in cultured hippocampal neurons. J. Neurochem. 91, 13221331.
  • Benes F. M. (1991) Evidence for neurodevelopment disturbances in anterior cingulate cortex of post-mortem schizophrenic brain. Schizophr. Res. 5, 187188.
  • Benes F. M. (1995) Altered glutamatergic and GABAergic mechanisms in the cingulate cortex of the schizophrenic brain. Arch. Gen. Psychiatry 52, 10151018; discussion 1019–1024.
  • Bi X., Chen J., Dang S., Wenthold R. J., Tocco G. and Baudry M. (1997) Characterization of calpain-mediated proteolysis of GluR1 subunits of alpha-amino-3-hydroxy-5-methylisoxazole-4-propionate receptors in rat brain. J. Neurochem. 68, 14841494.
  • Bi R., Bi X. and Baudry M. (1998a) Phosphorylation regulates calpain-mediated truncation of glutamate ionotropic receptors. Brain Res. 797, 154158.
  • Bi X., Rong Y., Chen J., Dang S., Wang Z. and Baudry M. (1998b) Calpain-mediated regulation of NMDA receptor structure and function. Brain Res. 790, 245253.
  • Brorson J. R., Marcuccilli C. J. and Miller R. J. (1995) Delayed antagonism of calpain reduces excitotoxicity in cultured neurons. Stroke 26, 12591266; discussion 1267.
  • Crocker S. J., Smith P. D., Jackson-Lewis V. et al. (2003) Inhibition of calpains prevents neuronal and behavioral deficits in an MPTP mouse model of Parkinson’s disease. J. Neurosci. 23, 40814091.
  • Dong Y. N., Waxman E. A. and Lynch D. R. (2004) Interactions of postsynaptic density-95 and the NMDA receptor 2 subunit control calpain-mediated cleavage of the NMDA receptor. J. Neurosci. 24, 1103511045.
  • Dong Y. N., Wu H. Y., Hsu F. C., Coulter D. A. and Lynch D. R. (2006) Developmental and cell-selective variations in N-methyl-D-aspartate receptor degradation by calpain. J. Neurochem. 99, 206217.
  • Etienne P. and Baudry M. (1987) Calcium dependent aspects of synaptic plasticity, excitatory amino acid neurotransmission, brain aging and schizophrenia: a unifying hypothesis. Neurobiol. Aging 8, 362366.
  • Gao X. M. and Tamminga C. A. (1994) An increase in NMDA-sensitive [3H]glutamate and [3H]kainate binding in hippocampus 24 hours after PCP. Neurosci. Lett. 174, 149153.
  • Garthwaite G. and Garthwaite J. (1986) Neurotoxicity of excitatory amino acid receptor agonists in rat cerebellar slices: dependence on calcium concentration. Neurosci. Lett. 66, 193198.
  • Guttmann R. P., Baker D. L., Seifert K. M., Cohen A. S., Coulter D. A. and Lynch D. R. (2001) Specific proteolysis of the NR2 subunit at multiple sites by calpain. J. Neurochem. 78, 10831093.
  • Guttmann R. P., Sokol S., Baker D. L., Simpkins K. L., Dong Y. and Lynch D. R. (2002) Proteolysis of the N-methyl-d-aspartate receptor by calpain in situ. J. Pharmacol. Exp. Ther. 302, 10231030.
  • Ikonomidou C., Bosch F., Miksa M., Bittigau P., Vockler J., Dikranian K., Tenkova T. I., Stefovska V., Turski L. and Olney J. W. (1999) Blockade of NMDA receptors and apoptotic neurodegeneration in the developing brain. Science 283, 7074.
  • Javitt D. C. and Zukin S. R. (1991) Recent advances in the phencyclidine model of schizophrenia. Am. J. Psychiatry 148, 13011308.
  • Kohr G. (2006) NMDA receptor function: subunit composition versus spatial distribution. Cell Tissue Res. 326, 439446.
  • Kutsuwada T., Kashiwabuchi N., Mori H. et al. (1992) Molecular diversity of the NMDA receptor channel. Nature 358, 3641.
  • Lei S. Z., Zhang D., Abele A. E. and Lipton S. A. (1992) Blockade of NMDA receptor-mediated mobilization of intracellular Ca2+ prevents neurotoxicity. Brain Res. 598, 196202.
  • Lei G., Xia Y. and Johnson K. M. (2007) The role of Akt-GSK-3beta signaling and synaptic strength in phencyclidine-induced neurodegeneration. Neuropsychopharmacology. Epub ahead of print.
  • Lewis D. A. (1997) Schizophrenia and disordered neural circuitry. Schizophr. Bull. 23, 529531.
  • Li P. A., Howlett W., He Q. P., Miyashita H., Siddiqui M. and Shuaib A. (1998) Postischemic treatment with calpain inhibitor MDL 28170 ameliorates brain damage in a gerbil model of global ischemia. Neurosci. Lett. 247, 1720.
  • Liao G. Y., Wagner D. A., Hsu M. H. and Leonard J. P. (2001) Evidence for direct protein kinase-C mediated modulation of N-methyl-D-aspartate receptor current. Mol. Pharmacol. 59, 960964.
  • Liu A., Hoffman P. W., Lu W. and Bai G. (2004) NF-kappaB site interacts with Sp factors and up-regulates the NR1 promoter during neuronal differentiation. J. Biol. Chem. 279, 1744917458.
  • Lu X., Rong Y. and Baudry M. (2000) Calpain-mediated degradation of PSD-95 in developing and adult rat brain. Neurosci. Lett. 286, 149153.
  • Luby E. D., Gottlieb J. S., Cohen B. D., Rosenbaum G. and Domino E. F. (1962) Model psychoses and schizophrenia. Am. J. Psychiatry 119, 6167.
  • Lynch D. R. and Guttmann R. P. (2002) Excitotoxicity: perspectives based on N-methyl-D-aspartate receptor subtypes. J. Pharmacol. Exp. Ther. 300, 717723.
  • Mauceri D., Gardoni F., Marcello E. and Di Luca M. (2007) Dual role of CaMKII-dependent SAP97 phosphorylation in mediating trafficking and insertion of NMDA receptor subunit NR2A. J. Neurochem. 100, 10321046.
  • McDonald J. W., Silverstein F. S., Cardona D., Hudson C., Chen R. and Johnston M. V. (1990) Systemic administration of MK-801 protects against N-methyl-D-aspartate- and quisqualate-mediated neurotoxicity in perinatal rats. Neuroscience 36, 589599.
  • McInnis J., Wang C., Anastasio N., Hultman M., Ye Y., Salvemini D. and Johnson K. M. (2002) The role of superoxide and nuclear factor-kappaB signaling in N-methyl-D-aspartate-induced necrosis and apoptosis. J. Pharmacol. Exp. Ther. 301, 478487.
  • Monyer H., Burnashev N., Laurie D. J., Sakmann B. and Seeburg P. H. (1994) Developmental and regional expression in the rat brain and functional properties of four NMDA receptors. Neuron 12, 529540.
  • Murray R. M., O’Callaghan E., Castle D. J. and Lewis S. W. (1992) A neurodevelopmental approach to the classification of schizophrenia. Schizophr. Bull. 18, 319332.
  • Nath R., Raser K. J., McGinnis K., Nadimpalli R., Stafford D. and Wang K. K. (1996) Effects of ICE-like protease and calpain inhibitors on neuronal apoptosis. Neuroreport 8, 249255.
  • Niethammer M., Kim E. and Sheng M. (1996) Interaction between the C terminus of NMDA receptor subunits and multiple members of the PSD-95 family of membrane-associated guanylate kinases. J. Neurosci. 16, 21572163.
  • Paoletti P. and Neyton J. (2007) NMDA receptor subunits: function and pharmacology. Curr. Opin. Pharmacol. 7, 3947.
  • Paxinos G. and Watson C. (1986) The rat brain in stereotaxic coordinates. Academic Press, Sydney; New York.
  • Pilowsky L. S., Kerwin R. W. and Murray R. M. (1993) Schizophrenia: a neurodevelopmental perspective. Neuropsychopharmacology 9, 8391.
  • Qin Z., Wang Y. and Chasea T. N. (2000) A caspase-3-like protease is involved in NF-kappaB activation induced by stimulation of N-methyl-D-aspartate receptors in rat striatum. Brain Res. Mol. Brain Res. 80, 111122.
  • Saido T. C., Sorimachi H. and Suzuki K. (1994) Calpain: new perspectives in molecular diversity and physiological-pathological involvement. FASEB J. 8, 814822.
  • Simpkins K. L., Guttmann R. P., Dong Y., Chen Z., Sokol S., Neumar R. W. and Lynch D. R. (2003) Selective activation induced cleavage of the NR2B subunit by calpain. J. Neurosci. 23, 1132211331.
  • Sircar R., Follesa P. and Ticku M. K. (1996) Postnatal phencyclidine treatment differentially regulates N-methyl-D-aspartate receptor subunit mRNA expression in developing rat cerebral cortex. Brain Res. Mol. Brain Res. 40, 214220.
  • Suvarna N., Borgland S. L., Wang J., Phamluong K., Auberson Y. P., Bonci A. and Ron D. (2005) Ethanol alters trafficking and functional N-methyl-D-aspartate receptor NR2 subunit ratio via H-Ras. J. Biol. Chem. 280, 3145031459.
  • Takadera T., Matsuda I. and Ohyashiki T. (1999) Apoptotic cell death and caspase-3 activation induced by N-methyl-D-aspartate receptor antagonists and their prevention by insulin-like growth factor I. J. Neurochem. 73, 548556.
  • Tran D. H., Gong R. and Tang S.-J. (2007) Differential roles of NR2A and NR2B subtypes in NMDA receptor-dependent protein synthesis in dendrites. Neuropharmacology 53, 252256.
  • Vanderklish P. W. and Bahr B. A. (2000) The pathogenic activation of calpain: a marker and mediator of cellular toxicity and disease states. Int. J. Exp. Pathol. 81, 323339.
  • Wang C. Z. and Johnson K. M. (2005) Differential effects of acute and subchronic administration on phencyclidine-induced neurodegeneration in the perinatal rat. J. Neurosci. Res. 81, 284292.
  • Wang C. Z. and Johnson K. M. (2007) The role of caspase-3 activation in phencyclidine-induced neuronal death in postnatal rats. Neuropsychopharmacology 32, 11781194.
  • Wang C., McInnis J., Ross-Sanchez M., Shinnick-Gallagher P., Wiley J. L. and Johnson K. M. (2001) Long-term behavioral and neurodegenerative effects of perinatal phencyclidine administration: implications for schizophrenia. Neuroscience 107, 535550.
  • Wang C., Fridley J. and Johnson K. M. (2005) The role of NMDA receptor upregulation in phencyclidine-induced cortical apoptosis in organotypic culture. Biochem. Pharmacol. 69, 13731383.
  • Waxman E. A. and Lynch D. R. (2005) N-methyl-D-aspartate receptor subtypes: multiple roles in excitotoxicity and neurological disease. Neuroscientist 11, 3749.
  • Wechsler A. and Teichberg V. I. (1998) Brain spectrin binding to the NMDA receptor is regulated by phosphorylation, calcium and calmodulin. EMBO J. 17, 39313939.
  • Weinberger D. R. (1987) Implications of normal brain development for the pathogenesis of schizophrenia. Arch. Gen. Psychiatry 44, 660669.
  • Wenthold R. J., Prybylowski K., Standley S., Sans N. and Petralia R. S. (2003) Trafficking of NMDA receptors. Annu. Rev. Pharmacol. Toxicol. 43, 335358.
  • Westbrook G. L., Krupp J. J. and Vissel B. (1997) Cytoskeletal interactions with glutamate receptors at central synapses. Soc. Gen. Physiol. Ser. 52, 163175.
  • Wilson M. A., Kinsman S. L. and Johnston M. V. (1998) Expression of NMDA receptor subunit mRNA after MK-801 treatment in neonatal rats. Brain Res. Dev. Brain Res. 109, 211220.
  • Wu H. Y. and Lynch D. R. (2006) Calpain and synaptic function. Mol. Neurobiol. 33, 215236.
  • Wu H. Y., Yuen E. Y., Lu Y. F., Matsushita M., Matsui H., Yan Z. and Tomizawa K. (2005) Regulation of N-methyl-D-aspartate receptors by calpain in cortical neurons. J. Biol. Chem. 280, 2158821593.
  • Wu H. Y., Hsu F. C., Gleichman A. J., Baconguis I., Coulter D. A. and Lynch D. R. (2007) Fyn-mediated phosphorylation of NR2B Tyr-1336 controls calpain-mediated NR2B cleavage in neurons and heterologous systems. J. Biol. Chem. 282, 2007520087.
  • Yamada Y., Chochi Y., Ko J. A., Sobue K. and Inui M. (1999) Activation of channel activity of the NMDA receptor-PSD-95 complex by guanylate kinase-associated protein (GKAP). FEBS Lett. 458, 295298.
  • Yamashima T. (2004) Ca2+-dependent proteases in ischemic neuronal death: a conserved ‘calpain-cathepsin cascade’ from nematodes to primates. Cell Calcium 36, 285293.
  • Zheng X., Zhang L., Wang A. P., Araneda R. C., Lin Y., Zukin R. S. and Bennett M. V. (1999) Mutation of structural determinants lining the N-methyl-D-aspartate receptor channel differentially affects phencyclidine block and spermine potentiation and block. Neuroscience 93, 125134.
  • Zhou M. and Baudry M. (2006) Developmental changes in NMDA neurotoxicity reflect developmental changes in subunit composition of NMDA receptors. J. Neurosci. 26, 29562963.